The Nuclein® Anywhere™ PCR Test is designed to be a disposable, all-in-one, self-test for infectious disease diagnosis. It uses standard real-time PCR, requires no technical expertise, and delivers battery-powered sample-to-answer results in under one hour. Please note that this testing device will require FDA regulatory clearance.
The Nuclein® Anywhere™ PCR Test is designed to offer a simple PCR to test for infectious disease, providing accurate answers in under one hour. On-the-spot, self-test results can be available anywhere, at the push of a button, with the same standard real-time PCR technology used by the U.S. Centers for Disease Control and Prevention (CDC), other government agencies, and commercial labs.
Our testing device represents a technological leap in point-of-care infectious disease testing and could enable robust expansion in the types of interactions medical professionals can have with their patients via telemedicine.
Our testing device has been designed to accept a saliva sample directly from the patient. From there, the diagnostic process can be activated by pushing a button, after which point the device automatically prepares the sample for analysis. Test results are then automatically displayed, in under one hour, as negative or positive on the LCD screen to the user.
Polymerase chain reaction (PCR) is a widely used technology that was first developed in 1983. The inventor was subsequently awarded the Nobel Prize, and PCR has long been a common and indispensable part of molecular biology. PCR is generally accepted as the gold standard in nucleic acid detection and is used for a broad variety of applications, including biomedical research, genetic testing and criminal forensics.
Our device is designed to run a real-time PCR reaction inside an all-in-one self-test, sample-to-answer, infectious disease testing solution.
How would this apply to COVID-19?
Please note that this testing device will require FDA regulatory clearance.